Live news related to VALERIO TX stock (FR0010095596): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALERIO TX mainly cover M&A activity. The stock trades at €0,66 on Euronext Paris, down 1,19% at the last update. This page lists the articles published on VALERIO TX stock to track the share price, company announcements and any item likely to influence market perception.
The biotechnology company provided an update on its project to acquire the entire share capital of Etherna Immunotherapies.Authorization regarding for…
The laboratory listed on Euronext Growth Paris finances in cash and securities the acquisition of a Belgian company specializing in messenger RNA, whi…
Valerio Therapeutics has signed a binding offer to acquire 100% of Etherna Immunotherapies, a specialist in mRNA and lipid nanoparticle technologies. …
Valerio Therapeutics announced on Tuesday the appointment of Gilles Besin as CEO, effective from July 1, 2026. This transition marks a pivotal change …
